retatrutide type 2 diabetes π©Ί in diabetes: TRANSCEND-T2D-1 Phase 3 results β HbA1c β2.0% + weight β16.8% at 40 weeks. A triple agonist that tackles both glycemia and obesity simultaneously. ππ Ref: Lilly ESC 2024: Retatrutide improves lipid
Pay in 4 interest-free payments of $5.30 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 1 - Aug 6




























